Fusai Tech: Robot Components in Early Trial Stage, No Revenue Generated

Fusai Technology has issued an official announcement regarding the abnormal fluctuation in its stock price, in response to the recent sharp rise in its shares. The announcement states that the company's stock experienced a cumulative deviation of 31.72% in closing price gains over three consecutive trading days—August 11, 12, and 13, 2026. According to the relevant rules of the Shenzhen Stock Exchange, this constitutes a situation of abnormal stock trading fluctuation. The company has conducted a self-inspection and confirmed that there are no undisclosed material matters, and its production and operations remain normal.

In the announcement, the company also addressed the status of its robot component business, which has drawn market attention. The robot component products are still in the early stage of research and development. The company has carried out small-batch trial production and has sent samples to some potential customers for evaluation. However, it is clearly stated that as of the first half of 2026, this business has not obtained any formal purchase orders, has not recognized any revenue, and has not realized any profit. Therefore, it has had no material impact on the company's current financial results. The company also cautioned that the future commercialization of this business remains uncertain, as factors such as technical maturity, market acceptance, and competition may affect its development.

The board of directors reminds investors to be mindful of investment risks and to view the short-term volatility rationally, without blindly following speculative trends. The company will strictly comply with relevant laws, regulations, and Shenzhen Stock Exchange requirements, and will promptly disclose any significant progress as required. Investors are advised to pay attention to subsequent announcements.